ONCSM vs ARCLK Comparison
Price, market cap, valuation, profitability and leverage metrics of ONCSM and ARCLK side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | ONCSM | ARCLK | Sector median |
|---|---|---|---|
| Last price (TL) | 83.75 | 84.75 | 18.72 |
| Daily change | −6.00% | −1.22% | −5.96% |
| Market cap | TRY 2B | TRY 57.3B | TRY 4.3B |
| P/E | 26.70 | — | 17.25 |
| P/B | 4.21 | 0.75 | 1.08 |
| Dividend yield | — | 1.71% | 0.90% |
| Return on equity | 18.26% | −4.06% | 1.78% |
| Free float | 40.86% | 17.46% | 37.21% |
Popular Comparisons
Related Pages
About the ONCSM vs ARCLK Comparison
Price, market cap, valuation multiples, profitability and leverage of ONCSM (Oncosem Onkolojik Sistemler) and ARCLK (Arçelik) side by side as of Sep 28, 2026, 15:52. Of the 15 metrics compared, ONCSM leads in 11 and ARCLK leads in 4.
Highlights: Daily change: ARCLK leads (−1.22% vs −6.00%). Market cap: ARCLK leads (TRY 57.3B vs TRY 2B). P/B: ARCLK leads (0.75 vs 4.21). EV/EBITDA: ONCSM leads (7.50 vs 9.31). EV/Sales: ARCLK leads (0.90 vs 4.76). Gross margin: ONCSM leads (54.30% vs 29.57%). EBITDA margin (annual): ONCSM leads (41.91% vs 14.15%). Net margin (annual): ONCSM leads (10.83% vs −0.60%).
Frequently Asked Questions
Is ONCSM or ARCLK cheaper?
By P/E, Tie is cheaper (26.70 vs —); by P/B, ARCLK trades at the lower multiple (4.21 vs 0.75).
Which is more profitable, ONCSM or ARCLK?
Annual net margin is 10.83% for ONCSM and −0.60% for ARCLK; return on equity is 18.26% for ONCSM and −4.06% for ARCLK.
Which is more leveraged, ONCSM or ARCLK?
The leverage ratio is 44.59 for ONCSM and 86.30 for ARCLK; net debt/EBITDA is 0.48 for ONCSM and 2.78 for ARCLK. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.